Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
She owns $NWBO stock?!? Lol. I’ll have to call her and invite her North.
I am trying to educate myself better on the mechanisms of naked short selling. Here is a YouTube video I watched earlier today regarding a historical perspective on naked short selling, the multiple levels of corruption and what NWBO is potentially up against (IMO). This is Patrick Byrnes experiences and no I have not checked the veracity of his claims but I believe him regardless of his politics and other scandals. “The greatest threat to Democracy is corruption.” Some scary David vs Goliath information. Hopefully the tides are turning.
Margaret
Anyone know for certain whose running FINRA? #Finrafraud is being tweeted that FINRA is run by the very criminals who are manipulating stock prices. See yesterday’s $AMAM stock movement. It went from $1.13 to $4.76 and end of day It closed at $4.54. I thought the after hours stock closures were weird. They significantly reduced the price and now EOD is $3.51?? There were a few halts by FINRA on the way up. What would happen if FINRA let the stock run?!? Who knows?
Margaret
Anyone else in Portugal? Lol
beartrap Be sure to thank Michael Bigger for sharing his savvy perspective of the attacks towards $NWBO. Citadel and company will prey on retail investor’s fear and Michael just explained how to look at this from a different perspective of excitement. Faith not fear will win the day IMO based on how the company is moving forward towards approval and manufacturing.
Take Care,
Margaret
Quoting Michael Bigger from Twitter:
$NWBO investors .. welcome the negativity. Polarization is an indication of what’s at stake .. massive potential. $AMZN 2001 $PCLN 2003 $CROX 2009 $PLUG 2013 .. Being ignored an indication of mediocrity.
Margaret
You need to cast your vote by 12/29
I voted my shares today in support of management. Everyone has a right to vote their conscience without criticism. We all own a piece of the company and vote with our shares as to what our motives are and what we believe in. Right or wrong? It’s a matter of perspective.
I know that the company is responsible for getting us this far and that I couldn’t have accomplished what they have. I doubt I could endure the attacks they have over the years and successfully survived. Kudos to Linda et. al. for their tenacity, drive, and passion in delivering success. They deserve their compensations for getting the company on the cusp of approval and commercialization. Cheers to NWBO and their partners for their dedication to creating a platform to cure cancer.
Well wishes to everyone,
Margaret
Thanks pgsd for your tenacity and follow through!
Margaret
I confirmed with ETrade this morning that cash only accounts are not lent out. For ETrade to lend out shares to shorts requires investors having a margin account. I still recommend everyone who doesn’t want their shares lent out to call their broker to make certain of this fact.
Prayers for the ultimate winners in this battle. All of the patients who desperately need better cancer treatments on the market as soon as possible.
Margaret
Another article referencing the JAMA journal article. Medscape is located in NY.
https://www.medscape.com/viewarticle/985104
Margaret
Due to buying these shares does the company have to wait a certain period of time before more PR’s are released? I don’t know the rules regarding insider purchases of a private offering. TIA!
Margaret
Yes I did. Thanks!
Good luck to cancer patients everywhere who deserve the DCVax platform be approved!
Margaret
Just listened to Dr. Liau’s talk on the successful P3 trial of DCVax. Can’t wait for FDA and other regulatory approvals based on the combination treatment. Data for over 50% survival in GBM! GO $NWBO #moonshot #GBM pic.twitter.com/bkSWsNwNNY
— Margaret Monson (@MonsonVO) December 6, 2022
Can someone explain then why the stock closed at $1.00 but my ETrade account is now showing $1.05? TIA
Margaret
The reason I support NWBO:
Sorry about the loss of your sister. I believe a lot of us long supporters of $NWBO have been touched by cancer in a very personal way. That is why we are passionate about getting DCVAX approved as a platform for curing GBM and other cancer indications. It also explains our rage.
— Margaret Monson (@MonsonVO) December 5, 2022
I have a question about the process of covering naked shorts. How do those with manufactured shares pay them off? Are they “sold” and the stock price goes down with a FTD later in the day? I’m not understanding how a squeeze works. TIA!
Margaret
lapetus, Thanks for your response to my questions.
Margaret
Thanks for that explanation Crash! I agree that the injunction will be granted based on the evidence submitted. I hope it is ruled on expeditiously. I’m assuming the defendants can appeal the decision of an injunction. Would that mean a stay of the injunction and basically giving the defendants room to delay and time for covering their positions (shorts or naked shorts)?
Sojo, You are right more often than not! Just think if the illegal manipulation wasn’t in play how much more accurate your TA would be. Thanks for all you’ve done for us and I’m glad you’re feeling better.
Take care,
Margaret
For our legal experts on here I have a question. After reading through the entire NWBO complaint, does the request for a permanent injunction have to wait until trial? Can a judge rule for a temporary injunction until trial or dismissal? TIA!
Good luck to all cancer patients and those who support them.
Margaret
I hope that we get JV/ Partnerships and NWBO continues the legal fight. These evildoers need to be exposed for their illegal and amoral behaviors instead of sweeping it under the proverbial rug. If we don’t stand fast in our litigation NWBO and other biotech companies suffer. We are on the cutting edge for cancer tx. Why not remove the cancers of Wall Street with our vaccine as well? A sort of two for one deal. Sounds like a great deal to me!
New article out referencing the JAMA paper out of China (I believe as there is no city listed in the article). I love the name of the online magazine: Medical World Phenomenon
https://www.cn-healthcare.com/articlewm/20221129/wap-content-1474918.html
Thanks BB. The longtime supporters of NWBO have weathered a fierce barrage of attacks. I have been here watching and now vocalizing since 2020 so a relative newbie. I am constantly surprised and impressed by the commitment of multiple longs to defend, support and get the word out about NWBO and the successful trial of Murcidencel (DCVax-L). The amount of expertise in multiple disciplines is amazing on IHub. I’m forever grateful to the longs who posted on IHub when I was first doing DD. If I had listened to the majority of posters on Yahoo back then, I would have panicked and sold immediately. Instead I investigated further and found IHub with intelligent posts that were grounded in fact and not fear. I’ve consistently added to my position since then and I am excited about our future.
GLTA especially the patients who need this drug approved asap.
Margaret
Yes for my vote! It would be unconscionable at this point in the process to tie the hands of management by voting no. We’ve known that they either needed a raise in the stock count or a R/S for some time. The 500,000,000 is less than I anticipated and is indicative of a conservative raise and an R/S at this point in time would be detrimental. All in my humble or not so humble opinion.
GLTA
Margaret
BB,
I don’t have PM’s so can’t respond privately. No I don’t know of him.
GLTA this Thanksgiving!
Margaret
Another media outlet from the UK issued this PR today:
https://ecancer.org/en/news/22419-dcvax-l-vaccination-improves-survival-for-newly-diagnosed-and-recurrent-glioblastoma
Happy Thanksgiving to all longs in the states! Well, and elsewhere too if you celebrate!!!
Margaret
Seeking Alpha article released an hour ago:
https://seekingalpha.com/article/4560104-northwest-biotherapeutics-stock-data-is-done-just-wait-for-approval
US News is starting. Both of these PR’s are from Denver, CO today per JAMA article altmetrics:
Bizwire Express and PR.com
https://jamanetwork.altmetric.com/details/138571371/news
Just the beginning…
Margaret
Prayers for your friend. It’s the terrible consequence of evil, greedy, and amoral attackers of a successful platform to cure cancers. I hate thinking vindictively of others but I believe there is a special place in Hell for those that manipulate the system for monetary gains regardless of the costs to humanity. It takes people like you who are on the frontlines defending the truth about the success of Murcidencel (DC-Vax L) and shining a light on the manipulation. Take care and so sorry to hear that your friend is suffering from this.
Margaret
I received this response a couple weeks ago from an email I sent on May 13th.
Dear Margaret,
Thank you submitting your idea to the White House Cancer Moonshot. We have read and acknowledge your submission. We appreciate your passion and commitment to help those impacted by cancer. We will explore your idea further, along with other solutions that will make meaningful progress for patients, survivors, and their loved ones.
In February, President Biden reignited the Cancer Moonshot and set bold new goals to decrease the cancer death rate by at least 50% over the 25 years and to improve the experience of people and families living with and surviving cancer. This spring, the Cancer Cabinet – which brings together leaders across the Biden Harris Administration as part of a whole-of-government approach to ending cancer as we know it – unveiled priority actions. These include: (1) close the screening gap; (2) understand and address environmental exposures; (3) decrease the impact of preventable cancers; (4) bring cutting edge research through the pipeline to patients and communities; and (5) support patients and caregivers. For more updates, visit whitehouse.gov/cancermoonshot.
President Biden’s goals for the Cancer Moonshot are big and bold and to get there, we know it will take all of us, working together, and working hard in every way we can, to move the mission forward.
Thank you again for your engagement and time,
The Cancer Moonshot Team
Well wishes to patients, NWBO, Dr. Liau et. al., and those who support the science behind Murcidencel (DC-Vax L),
Margaret
As requested 29k upvotes
It’s what Reddit calls their like button.
I only saw 330 upvotes for the Guardian article. Where did you see 10,700?
I found it! 25,300 upvotes now!
https://www.reddit.com/r/science/comments/yy2651/vaccine_doubles_brain_tumour_survival_rate_in/?utm_source=share&utm_medium=ios_app&utm_name=iossmf
I remember seeing a presentation that BP would want to partner with NWBO rather than squelch NWBO. Does anyone else remember that video? It was a discussion where DCVAX would enhance BP’s products and that they’d want to partnership with NWBO vs. kill the company?
NWBO has been attacked when they communicate excellent results. If you were in their position what would you do differently? I would say as little as possible until I had all my ducks lined up. The quiet period covers both the journal article and short attacks. IMHO
Prayers for the patients, NWBO employees, scientists involved with Murcidencel and of course all of the investors who believe in finding a cure for cancer.
Margaret
What peeked my interest was the CME on Thursday with Dr. Brem. Notice the last line:
There's still time to register for the CME, PeerView.com/2022GBM-Live, developed in partnership with ABTA, Thursday, 11.17.22, 5:15 PM, dinner, Ballroom D, Tampa Convention Center, organized by @PeerView, featuring @BrainTumorDoc and Suriya Jeyapalan. Will preview CTIM-27, DCVax.
Well wishes to patients, NWBO, Dr. Liau, all of the doctors who worked on murcindencel, and all the long time investors.
Margaret
I got shot down on my previous post due due TTF being presented:
Magrit
Re: None
Thursday, 11/03/2022 4:16:07 PM
I noticed these additional presentations at SNO:
Independent Supported Sessions at SNO
27th Annual Meeting and Education Day of the Society for Neuro-Oncology
November 16 - 20, 2022
Date: Wednesday, November 16, 2022
Time: 8:00AM – 4:30PM
Therapeutic Development in NeuroOncology Symposium
Location: Ballroom C, Tampa Convention Center
Symposium Chairs: Michael Vogelbaum MD, PhD and Peter Forsyth MD – Moffitt Cancer Center, Tampa, Florida
Speakers: For a full list of all of the speakers, click here.
On the list of speakers is:
Timothy Cloughesy
Professor of Neurology and Molecular and Medical Pharmacology
UCLA Health
In addition Dr. Stephen Brem will be speaking as well:
Date: Thursday, November 17, 2022
Time: 5:30PM – 7:30PM
Setting Our Sights on Improved Outcomes in Glioblastoma: State-of-the-Art Care with Tumor Treating Fields and Other Innovative Approaches
Location: Ballroom D, Tampa Convention Center
Speakers:
Steven Brem, MD - Penn Brain Tumor Center, Philadelphia, Pennsylvania
Manmeet Ahluwalia, MD, MBA - Miami Cancer Institute, Miami, Florida
Suriya Jeyapalan, MD, MPH - Tufts Medical Center, Boston, Massachusetts
Innovative science is poised to transform glioblastoma management by offering the opportunity to enhance conventional management through the use of newer modalities, including tumor treating fields (TTFields) and efficacious systemic therapies. These novel options have been incorporated into clinical practice guidelines and are driving improved outcomes for patients with newly diagnosed and recurrent disease. The current challenge is how best to use these modalities in sequential combination strategies across glioblastoma treatment settings.
In a new “Seminars & Practicum” event, expert panelists will link current science to practical decisions that can help clinicians “set their sights” on achieving improved outcomes in glioblastoma. Throughout the lecture and case-based segments, the experts will provide context for the real-world impact of glioblastoma, focus on the latest data on TTFields, discuss TTFields delivery considerations, and address the integration of targeted and biomarker-guided therapies into glioblastoma management. This program will also feature patient perspectives,
Looking forward to DCVax being available to those suffering from cancer.
Margaret
Release of Dr. Liau’s abstract OR short manipulation. IMHO